These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 19183238)

  • 21. Current status of virtual screening as analysed by target class.
    Stoermer MJ
    Med Chem; 2006 Jan; 2(1):89-112. PubMed ID: 16787359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In silico fragment screening by replica generation (FSRG) method for fragment-based drug design.
    Fukunishi Y; Mashimo T; Orita M; Ohno K; Nakamura H
    J Chem Inf Model; 2009 Apr; 49(4):925-33. PubMed ID: 19354203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. De Novo Design of Ligands Using Computational Methods.
    Suryanarayanan V; Panwar U; Chandra I; Singh SK
    Methods Mol Biol; 2018; 1762():71-86. PubMed ID: 29594768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of computational methods in the identification of bioactive compounds.
    Glick M; Jacoby E
    Curr Opin Chem Biol; 2011 Aug; 15(4):540-6. PubMed ID: 21411361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Virtual fragment screening: discovery of histamine H3 receptor ligands using ligand-based and protein-based molecular fingerprints.
    Sirci F; Istyastono EP; Vischer HF; Kooistra AJ; Nijmeijer S; Kuijer M; Wijtmans M; Mannhold R; Leurs R; de Esch IJ; de Graaf C
    J Chem Inf Model; 2012 Dec; 52(12):3308-24. PubMed ID: 23140085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NMR and in silico screening.
    Rüdisser S; Jahnke W
    Comb Chem High Throughput Screen; 2002 Dec; 5(8):591-603. PubMed ID: 12470256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel technologies for virtual screening.
    Lengauer T; Lemmen C; Rarey M; Zimmermann M
    Drug Discov Today; 2004 Jan; 9(1):27-34. PubMed ID: 14761803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Managing protein flexibility in docking and its applications.
    B-Rao C; Subramanian J; Sharma SD
    Drug Discov Today; 2009 Apr; 14(7-8):394-400. PubMed ID: 19185058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Virtual screening in drug discovery -- a computational perspective.
    Reddy AS; Pati SP; Kumar PP; Pradeep HN; Sastry GN
    Curr Protein Pept Sci; 2007 Aug; 8(4):329-51. PubMed ID: 17696867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-guided fragment screening for lead discovery.
    Verdonk ML; Hartshorn MJ
    Curr Opin Drug Discov Devel; 2004 Jul; 7(4):404-10. PubMed ID: 15338949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fragment-based lead discovery: a chemical update.
    Erlanson DA
    Curr Opin Biotechnol; 2006 Dec; 17(6):643-52. PubMed ID: 17084612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LS-align: an atom-level, flexible ligand structural alignment algorithm for high-throughput virtual screening.
    Hu J; Liu Z; Yu DJ; Zhang Y
    Bioinformatics; 2018 Jul; 34(13):2209-2218. PubMed ID: 29462237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In silico fragment-based discovery of DPP-IV S1 pocket binders.
    Rummey C; Nordhoff S; Thiemann M; Metz G
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1405-9. PubMed ID: 16321524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toward fully automated high performance computing drug discovery: a massively parallel virtual screening pipeline for docking and molecular mechanics/generalized Born surface area rescoring to improve enrichment.
    Zhang X; Wong SE; Lightstone FC
    J Chem Inf Model; 2014 Jan; 54(1):324-37. PubMed ID: 24358939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using computational techniques in fragment-based drug discovery.
    Desjarlais RL
    Methods Enzymol; 2011; 493():137-55. PubMed ID: 21371590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Function and structure-based screening of compounds, peptides and proteins to identify drug candidates.
    Malik V; Dhanjal JK; Kumari A; Radhakrishnan N; Singh K; Sundar D
    Methods; 2017 Dec; 131():10-21. PubMed ID: 28843611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrating sampling techniques and inverse virtual screening: toward the discovery of artificial peptide-based receptors for ligands.
    Pérez GM; Salomón LA; Montero-Cabrera LA; de la Vega JM; Mascini M
    Mol Divers; 2016 May; 20(2):421-38. PubMed ID: 26553204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure-based virtual screening: an overview.
    Lyne PD
    Drug Discov Today; 2002 Oct; 7(20):1047-55. PubMed ID: 12546894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Virtual screening for the discovery of bioactive natural products.
    Rollinger JM; Stuppner H; Langer T
    Prog Drug Res; 2008; 65():211, 213-49. PubMed ID: 18084917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Machine learning in computational docking.
    Khamis MA; Gomaa W; Ahmed WF
    Artif Intell Med; 2015 Mar; 63(3):135-52. PubMed ID: 25724101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.